Rep. April McClain Delaney Buys STERIS plc (NYSE:STE) Shares

Key Points

• Rep. April McClain Delaney purchased between $1,001 and $15,000 of STERIS plc (NYSE:STE) stock on April 30, 2026, a trade disclosed in a filing on May 6.
• STERIS fundamentals and dividend: the company has a market cap of about $20.99 billion, a trailing P/E near 29.9, reported quarterly EPS of $2.53 with revenue up 9.2% year‑over‑year, and declared a $0.63 quarterly dividend (ex‑dividend June 8, payable June 26; annualized $2.52, ~1.2% yield).
• Market sentiment and ownership: analysts maintain a "Moderate Buy" consensus target of $275.20 amid some recent downgrades, insiders own ~1.07% of the stock while institutional investors hold roughly 94.7%.

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of STERIS plc NYSE: STE. In a filing disclosed on May 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in STERIS stock on April 30th.

Representative April McClain Delaney also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Service Corporation International NYSE: SCI on 4/30/2026.
• Purchased $1,001 - $15,000 in shares of Markel Group NYSE: MKL on 4/30/2026.
• Sold $1,001 - $15,000 in shares of Clean Harbors NYSE: CLH on 4/30/2026.
• Purchased $1,001 - $15,000 in shares of Transdigm Group NYSE: TDG on 4/29/2026.
• Purchased $1,001 - $15,000 in shares of Packaging Corporation of America NYSE: PKG on 4/29/2026.
• Purchased $1,001 - $15,000 in shares of Packaging Corporation of America NYSE: PKG on 4/24/2026.
• Purchased $1,001 - $15,000 in shares of Nasdaq NASDAQ: NDAQ on 4/24/2026.
• Sold $1,001 - $15,000 in shares of Fortune Brands Innovations NYSE: FBIN on 4/24/2026.
• Sold $15,001 - $50,000 in shares of C.H. Robinson Worldwide NASDAQ: CHRW on 4/24/2026.
• Sold $1,001 - $15,000 in shares of Paychex NASDAQ: PAYX on 4/21/2026.

STERIS Stock Performance

NYSE:STE opened at $214.02 on Friday. The company has a quick ratio of 1.75, a current ratio of 2.48 and a debt-to-equity ratio of 0.26. The company has a market cap of $20.99 billion, a P/E ratio of 29.85 and a beta of 0.95. STERIS plc has a fifty-two week low of $195.14 and a fifty-two week high of $269.44. The firm's 50 day moving average is $224.30 and its two-hundred day moving average is $244.27.

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, hitting analysts' consensus estimates of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. The business's revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.32 EPS. Analysts expect that STERIS plc will post 10.22 EPS for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 8th will be paid a dividend of $0.63 per share. The ex-dividend date of this dividend is Monday, June 8th. This represents a $2.52 dividend on an annualized basis and a yield of 1.2%. STERIS's dividend payout ratio (DPR) is currently 35.15%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on STE shares. Weiss Ratings downgraded shares of STERIS from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Thursday, April 16th. Wall Street Zen downgraded shares of STERIS from a "strong-buy" rating to a "buy" rating in a research note on Sunday, April 26th. Five equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $275.20.

Insiders Place Their Bets

In other STERIS news, Director Cynthia L. Feldmann sold 3,098 shares of the firm's stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total transaction of $734,876.58. Following the completion of the transaction, the director directly owned 705 shares of the company's stock, valued at $167,233.05. This trade represents a 81.46% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.07% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On STERIS

Several large investors have recently made changes to their positions in the business. Nordea Investment Management AB grew its holdings in STERIS by 259.0% during the 4th quarter. Nordea Investment Management AB now owns 51,602 shares of the medical equipment provider's stock valued at $13,165,000 after purchasing an additional 37,228 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in STERIS by 9.4% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,039,351 shares of the medical equipment provider's stock valued at $257,157,000 after purchasing an additional 89,250 shares in the last quarter. Asset Management One Co. Ltd. grew its holdings in STERIS by 5.4% during the 3rd quarter. Asset Management One Co. Ltd. now owns 98,487 shares of the medical equipment provider's stock worth $24,366,000 after acquiring an additional 5,072 shares in the last quarter. Legal & General Group Plc grew its holdings in STERIS by 5.3% during the 3rd quarter. Legal & General Group Plc now owns 693,116 shares of the medical equipment provider's stock worth $171,505,000 after acquiring an additional 34,981 shares in the last quarter. Finally, Elo Mutual Pension Insurance Co acquired a new position in STERIS during the 3rd quarter worth $2,480,000. Institutional investors and hedge funds own 94.69% of the company's stock.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland's 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland's 6th Congressional District. She declared candidacy for the 2026 election. April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor's degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

STERIS Company Profile

STERIS Corporation NYSE: STE is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.